2009 Leadership Retreat - Complications Scientific Committee Business Meeting

 

 

Chair:                         Sharon Nachman, M.D. 

          Vice Chair:               Myron Levin, M.D.

 

 

Monday, December 7, 2009     v     2:15 P.M. – 5:00 P.M.

Brief Summary of Enrollment to Complications Studies (2009)

-     Sharon Nachman, M.D.

Complications Scientific Committee Studies to be Opened

-     Myron Levin, M.D.

New Targets for Studies:

-     Tuberculosis (TB) - Mark Cotton, M.D.

-     Hepatitis B - William Borkowsky, M.D.

-     Malaria-TBD

-     Dengue - Virat Sirisanthana, M.D.

Review of CAP 250 “Safety and immunogenicity of a seasonal trivalent inactivated influenza vaccine, with influenza A H1N1 component, in HIV-infected pregnant women in Johannesburg, South Africa”

- Coceka Mnyani, M.D.